Download PDF
psychoneuro 2006; 32(7/08): 350-362
DOI: 10.1055/s-2006-951440
Schwerpunkt

© Georg Thieme Verlag Stuttgart · New York

Behandlung psychotischer Ersterkrankter

Martin Lambert1
  • 1Psychosen Ersterkennungs- und Behandlungsprojekt (PEB), Zentrum für Psychosoziale Medizin, Klinik und Poliklinik für Psychiatrie und Psychotherapie der Universität Hamburg
Further Information

Publication History

Publication Date:
28 August 2006 (online)

    Permissions and Reprints

Psychotische Symptome kommen bei einer Reihe psychischer Störungen vor. Psychotische Störungen verlaufen in Phasen. Unterschieden werden prämorbide und prodromale Phase, die Phase (Dauer) der unbehandelten Psychose (englisch: „Duration of Untreated Psychosis”; DUP), die Ersterkrankungsphase und die chronische bzw. residuale Phase. Die DUP ist deshalb von Bedeutung, weil sie mit biopsychosozialen Folgeschäden und Konsequenzen verbunden sein kann, die größtenteils eine schlechte Prognose im weiteren Verlauf der Erkrankung begünstigen. Psychotische Erstmanifestationen stellen hochkomplexe psychische Störungen dar. Dementsprechend hängen der kurz- bzw. langfristige Verlauf der Erkrankung und damit die Prognose maßgeblich von der Qualität der Erstbehandlung ab. Hier müsste das bestehende Versorgungssystem zugunsten von regional organisierten, spezialisierten Zentren in integrierter Zusammenarbeit mit niedergelassenen Nervenärzten umstrukturiert werden, die von Anfang eine langfristige, setting- und altersübergreifende, multimodaler Behandlung anbieten.

Key Words

first-episode psychosis - schizophrenia - pharmacotherapy - setting - shared decision making

Literatur

  • 1 Amminger GP. et al. .Treated incidence of first-episode psychosis in the catchment area of EPPIC between 1997 and 2000. Acta Psychiatrica Scand, in press
    Google Scholar
  • 2 Ballageer T. et al. . Is adolescent-onset first-episode psychosis different from adult onset?.  J Am Acad Child Adolesc Psychiatry. 2005;  44 782-9
    Google Scholar
  • 3 Bellack AS, DiClemente CC. Treating substance abuse among patients with schizophrenia.  Psychiatr Serv. 1999;  50 75-80
    PubMedGoogle Scholar
  • 4 Bellack AS. et al. . A randomized clinical trial of a new behavioral treatment for drug abuse in people with severe and persistent mental illness.  Arch Gen Psychiatry. 2006;  63 426-32
    CrossrefPubMedGoogle Scholar
  • 5 Bowie CR, Harvey PD. Cognition in schizophrenia: impairments, determinants, and functional importance.  Psychiatr Clin North Am. 2005;  28 613-33
    CrossrefPubMedGoogle Scholar
  • 6 Carlsson R. et al. . Neuropsychological functions predict 1- and 3-year outcome in first-episode psychosis.  Acta Psychiatr Scand. 2006;  113 102-11
    CrossrefPubMedGoogle Scholar
  • 7 Day JC. et al. . Attitudes toward antipsychotic medication: the impact of clinical variables and relationships with health professionals.  Arch Gen Psychiatry. 2005;  62 717-24
    CrossrefPubMedGoogle Scholar
  • 8 de Haan L. et al. . Opinions of mothers on the first psychotic episode and the start of treatment of their child.  Eur Psychiatry. 2004;  19 226-9
    CrossrefPubMedGoogle Scholar
  • 9 Dickerson FB, Lehman AF. Evidence-based psychotherapy for schizophrenia.  J Nerv Ment Dis. 2006;  194 3-9
    PubMedGoogle Scholar
  • 10 Fleischhacker WW, Naber D, Lambert M. Psychopharmakotherapie der Schizophrenie.  In: Vorderholzer U, Hohagen F (Hrsg). Therapie psychischer Erkrankungen State of the Art.  Urban & Fischer. 2005;  49-73
    PubMedGoogle Scholar
  • 11 Goodwin RD. et al. . Anxiety and substance use comorbidity among inpatients with schizophrenia.  Schizophr Res. 2003;  61 89-95
    CrossrefPubMedGoogle Scholar
  • 12 Granholm E. et al. . A randomized, controlled trial of cognitive behavioral social skills training for middle-aged and older outpatients with chronic schizophrenia.  Am J Psychiatry. 2005;  162 520-9
    Google Scholar
  • 13 Guy W. ECDEU Assessment Manual for Psychopharmacology, revised. DHEW Pub. No. (ADM) 76-338. National Institute of Mental Health, Rockville 1976
    Google Scholar
  • 14 Hamann J. et al. . Do patients with schizophrenia wish to be involved in decisions about their medical treatment?.  Am J Psychiatry. 2005;  162 2382-4
    CrossrefPubMedGoogle Scholar
  • 15 Harrigan SM, McGorry PD, Krstev H. Does treatment delay in first-episode psychosis really matter?.  Psychol Med. 2003;  33 97-110
    CrossrefPubMedGoogle Scholar
  • 16 Haynes RB. et al. . Interventions to enhance medication adherence.  Cochrane Database Syst Rev. 2005;  19
    PubMedGoogle Scholar
  • 17 Jablensky A. et al. . Schizophrenia: manifestations, incidence and course in different cultures. A World Health Organization ten-country study.  Psychol Med Monogr Suppl. 1992;  20 1-97
    PubMedGoogle Scholar
  • 18 Jackson H. et al. . Cognitively oriented psychotherapy for early psychosis (COPE): a 1-year follow-up.  Br J Clin Psychol. 2001;  40 57-70
    CrossrefPubMedGoogle Scholar
  • 19 Jones C. et al. . Cognitive behaviour therapy for schizophrenia.  Cochrane Database Syst Rev. 2004;  18
    PubMedGoogle Scholar
  • 20 Lambert M. et al. . Pharmacotherapy of first-episode schizophrenia.  Expert Opinion on Pharmacotherapy. 2003;  4 717-751
    CrossrefPubMedGoogle Scholar
  • 21 Lambert M. et al. . The impact of substance use disorders on clinical outcome in 668 patients with first-episode psychosis.  Acta Psychiatrica Scand. 2005;  112 141-148
    Google Scholar
  • 22 Lambert M, Naber D. Current schizophrenia. Science Press Ltd 2004
    Google Scholar
  • 23 Lambert M. et al. .Den Weg nach Vorne finden: Unterstützung Hilfe und Orientierung für alle von Schizophrenie Betroffenen. 2006
    Google Scholar
  • 24 Lambert M. et al. .Remission of severely impaired subjective well-being in 727 patients with schizophrenia treated with amisulpride. Acta Psychiatrica Scand, in press
    Google Scholar
  • 25 Malla AK. et al. . Predictors of rate and time to remission in first-episode psychosis: a two-year outcome study.  Psycholol Med. 2006;  16 1-10
    PubMedGoogle Scholar
  • 26 Marshall M, Lockwood A. Assertive community treatment for people with severe mental disorders. Cochrane Database Syst Rev 2000 2
    Google Scholar
  • 27 Marshall M. et al. . Systematic reviews of the effectiveness of day care for people with severe mental disorders: (1) acute day hospital versus admission; (2) vocational rehabilitation; (3) day hospital versus outpatient care.  Health Technol Assess. 2001;  5 1-75
    PubMedGoogle Scholar
  • 28 Marshall M. et al. . Association between duration of untreated psychosis and outcome in cohorts of first-episode patients: a systematic review.  Arch Gen Psychiatry. 2005;  62 975-83
    Google Scholar
  • 29 Mattsson M. et al. . Background factors as determinants of satisfaction with care among first-episode psychosis patients.  Soc Psychiatry Psychiatr Epidemiol. 2005;  40 749-54
    CrossrefPubMedGoogle Scholar
  • 30 McGorry PD. et al. . Royal Australian and New Zealand College of Psychiatrists Clinical Practice Guidelines Team for the Treatment of Schizophrenia and Related Disorders. Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for the treatment of schizophrenia and related disorders.  Aust N Z J Psychiatry. 2005;  39 1-30
    Google Scholar
  • 31 Miller WR. et al. .Motivational Enhancement Therapy with Drug Abusers. Washington, DC: US Government Printing Office 1992
    Google Scholar
  • 32 Moran P, Hodgins S. The correlates of comorbid antisocial personality disorder in schizophrenia.  Schizophr Bull. 2004;  30 791-802
    CrossrefPubMedGoogle Scholar
  • 33 Naber D. et al. . Improvement of schizophrenic patients subjective well-being under atypical antipsychotic drugs.  Schizophr Res. 2001;  50 79-88
    CrossrefPubMedGoogle Scholar
  • 34 Pekkala E, Merinder L. Psychoeducation for schizophrenia.  Cochrane Database Syst Rev. 2002;  2
    PubMedGoogle Scholar
  • 35 Penn DL. et al. . Psychosocial treatment for first-episode psychosis: a research update.  Am J Psychiatry. 2005;  162 2220-32
    CrossrefPubMedGoogle Scholar
  • 36 Perkins D. et al. . Predictors of antipsychotic treatment response in patients with first-episode schizophrenia, schizoaffective and schizophreniform disorders.  Br J Psychiatry. 2004;  185 18-24
    CrossrefPubMedGoogle Scholar
  • 37 Petersen L. et al. . A randomised multicentre trial of integrated versus standard treatment for patients with a first episode of psychotic illness.  BMJ. 2005;  331 602
    Google Scholar
  • 38 Pharoah FM. et al. . Family intervention for schizophrenia.  Cochrane Database Syst Rev. 2003;  4
    PubMedGoogle Scholar
  • 39 Pitschel-Walz G. et al. . Psychoeducation and compliance in the treatment of schizophrenia: results of the Munich Psychosis Information Project Study.  J Clin Psychiatry. 2006;  67 443-52
    Google Scholar
  • 40 Poyurovsky M, Fuchs C, Weizman A. Obsessive-compulsive disorder in patients with first-episode schizophrenia.  Am J Psychiatry. 1999;  156 1998-2000
    PubMedGoogle Scholar
  • 41 Rund BR. et al. . Neurocognitive dysfunction in first-episode psychosis: correlates with symptoms, premorbid adjustment, and duration of untreated psychosis.  Am J Psychiatry. 2004;  161 466-472
    CrossrefPubMedGoogle Scholar
  • 42 Sato T. et al. . Psychopathology of early-onset schizophrenia versus late-onset schizophrenia revisited: an observatin of 473 neuroleptic-naive patients before and after first-admission treatments.  Schizophr Res. 2004;  67 175-183
    CrossrefPubMedGoogle Scholar
  • 43 Schimmelmann B. et al. . Diagnostic stability 18-month after a first diagnosis of psychosis.  J Clin Psychiatry. 2005;  66 1239-1246
    Google Scholar
  • 44 Schimmelmann B. et al. .Predictors of non-adherence with treatment in first-admitted adolescents with psychosis. J Am Acad Child Adol Psychiatry, in press
    Google Scholar
  • 45 Sim K. et al. . Psychiatric comorbidity in first episode psychosis: the Early Psychosis Intervention Program (EPIP) experience.  Acta Psychiatr Scand. 2004;  109 23-9
    CrossrefPubMedGoogle Scholar
  • 46 Schwartz JE. et al. . Congruence of diagnoses 2 years after a first-admission diagnosis of psychosis.  Arch Gen Psychiatry. 2000;  57 593-600
    CrossrefPubMedGoogle Scholar
  • 47 Tarrier N. et al. . Cognitive-behavioural therapy in first-episode and early schizophrenia. 18-month follow-up of a randomised controlled trial.  Br J Psychiatry. 2004;  184 231-9
    CrossrefPubMedGoogle Scholar
  • 48 Tarrier N. Cognitive behaviour therapy for schizophrenia - a review of development, evidence and implementation.  Psychother Psychosom. 2005;  74 136-44
    CrossrefPubMedGoogle Scholar

Korrespondenzadresse:

PD Dr. Martin Lambert

Psychosen Ersterkennungs- und Behandlungsprojekt (PEB)

Zentrum für Psychosoziale Medizin

Klinik und Poliklinik für Psychiatrie und Psychotherapie des Universitätsklinikums Hamburg-Eppendorf

Martinistr. 52

20246 Hamburg

Email: lambert@uke.uni-hamburg.de

      >